Koers Xtant Medical Holdings Inc Nyse
Aandelen
US98420P1003
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 115 mln. 108 mln. | Omzet 2025 * | 130 mln. 122 mln. | Marktkapitalisatie | 116 mln. 109 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,48 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 1,01 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,89 x |
K/w-verhouding 2024 * |
-14,9
x | K/w-verhouding 2025 * |
-179
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,7% |
Recentste transcriptie over Xtant Medical Holdings Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Browne
CEO | Chief Executive Officer | 58 | 07-10-19 |
Scott Neils
DFI | Director of Finance/CFO | 40 | 01-08-19 |
Chief Operating Officer | - | 16-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 58 | 16-05-23 | |
John Bakewell
BRD | Director/Board Member | 62 | 01-02-18 |
Robert McNamara
BRD | Director/Board Member | 67 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,45% | 10,69 mld. | |
+2,17% | 8,93 mld. | |
+19,11% | 7,32 mld. | |
+26,08% | 4,82 mld. | |
+7,18% | 3,4 mld. | |
-0,80% | 3,03 mld. | |
-5,07% | 2,23 mld. | |
-4,22% | 2,13 mld. | |
-20,87% | 1,84 mld. |